Some people on this board keep trying to discredit TLT management.
Here is just a small list of TLT management accomplisments.
Theralase has the best PDT treatment ever to be in a FDA phase11 trial.
Theralase has the first PDT treatment in a FDA phase11 trial on the verge of receiving the FDA BTD approval.
Theralase has the only NMIBC treatment for BCG resistant patients, 100% safe, and with no restrictions, that is big.
Theralase PDT treatment has the highest Duration Of Response of all treatments for BCG resistant patients, another big one.
Theralase has a huge pipeline(very huge).
And yet on a daily basis, people keep trying to discredit TLT management.
I have nothing agains critisizing TLT management, but if you ask these complainers to name a single management team that
did get a new cancer treatment with top-notch data so far in the FDA approval process, and with so little money, and only 300 million shares out. The only answer you get is ,I am a couch potato quaterback, and I am alowed to discredit TLT management without proving my point.
Lets be clear on something, I am not saying that TLT management was perfect and didn't make mistake. What I am saying is that mistakes and delays are part of the approval process.
Best exemple:
ImmunityBio Anktiva(N-803+BCG) For BCG resistant cancer patients.
ImmunityBio did get a big delay, and did lose temporally its Biological License Application, because the FDA had an issue with the manufacturing process.
FDA rejects ImmunityBio’s bladder cancer drug | pharmaphorum As you can see, nobody is perfect.
What these couch potato quaterback fail to say is, right now this management team is on the verge of getting the FDA BTD approval, and BTD approval will send the SP skyhight.
What these couch potato quaterback fail to say is,that this management team with the help of DrLBiati, is getting closer and closer to a big pharma deal.
And a BTD approval + a big pharma JV deal will send the SP to the stratosphere.
To the new investors on this board, contrary to what the couch potato quaterback are saying, in this article it said,''
that TLT has a very good and experienced management team and no debt '', that is also big.
When Will Theralase Technologies Inc. (CVE:TLT) Become Profitable? BTD approval + a juicy big pharma JV deal, will certainly send the SP to the stratosphere.